Y-mabs Therapeutics Inc. Stock Performance
as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
$8.59$8.61
0.12%
Downside
0.12%
Upside
52 Week's Low
52 Week's High
$3.55$16.1158.72%
Downside
87.33%
Upside
Y-mabs Therapeutics Inc. share price movements today
- Previous Close
- $8.59
- Open
- $8.59
- Volume
- 803.7K
- Day's Low - High
- $8.59 - $8.61
- 52 Week Low - High
- $3.55 - $16.11
Y-mabs Therapeutics Inc. Historical Returns
- 1 Month Return
- + 0.82 %
- 3 Month Return
- + 82.38 %
- 1 Year Return
- -37.48 %
- 3 Year Return
- -40.76 %
- 5 Year Return
- -78.18 %
Y-mabs Therapeutics Inc. Stock Fundamentals & Key Indicators
Check Y-mabs Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$390.3M
EPS (TTM)
-0.8044
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-25.39
Industry PE ratio
-3.8535542168674697
P/B Ratio
0PEG Ratio
0EBITDA
-17.8M
Revenue (TTM)
85.4M
Profit Margin
-26.03%
Return On Equity TTM
8353100.00%
Y-mabs Therapeutics Inc. Stock Valuation
Track how Y-mabs Therapeutics Inc. P/E has moved over time to understand its valuation trends.
Y-mabs Therapeutics Inc. in the last 5 years
Lowest (0.00x)
September 15, 2025
Today (-25.39x)
September 15, 2025
Industry (-3.85x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -25.39x
Y-mabs Therapeutics Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Y-mabs Therapeutics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $390.3M | -78.18% | -25.39 | -26.03% | |
| BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
| BUY | $59.4B | -3.43% | 14.11 | 31.37% |
Stock Returns calculator for Y-mabs Therapeutics Inc. Stock including INR - Dollar returns
The Y-mabs Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Y-mabs Therapeutics Inc. investment value today
Current value as on today
₹67,576
Returns
Returns from Y-mabs Therapeutics Inc. Stock
Dollar Returns*
₹4,985 (+4.99%)
Analyst Recommendation on Y-mabs Therapeutics Inc. Stock
Based on 13 analysts
76.92%
Buy
15.38%
Hold
7.69%
Sell
Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Y-mabs Therapeutics Inc.. Average target price of $8.6
Y-mabs Therapeutics Inc. Share Price Target
Get share price movements and forecasts by analysts on Y-mabs Therapeutics Inc..
Target Price
$8.6
Current Price
$8.6
Analyzed by
13 Analysts
Target
$8.60
Y-mabs Therapeutics Inc. target price $8.6, a slight upside of 0% compared to current price of $8.6. According to 13 analysts rating.
Y-mabs Therapeutics Inc. Stock's Interest Amongst Investors
Search interest for Y-mabs Therapeutics Inc. Stock has decreased by -91% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Y-mabs Therapeutics Inc. Quarterly Profit & Loss
All numbers in Millions USD
Y-mabs Therapeutics Inc. Annual Profit & Loss
All numbers in Millions USD
Y-mabs Therapeutics Inc. Quarterly Cash Flow
All numbers in Millions USD
Y-mabs Therapeutics Inc. Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Y-mabs Therapeutics Inc.
Insights on Y-mabs Therapeutics Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, YMAB stock has moved up by 82.4%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, -9.24M → -3.23M (in $), with an average increase of 31.6% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 164.3%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 113.1%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 26.49M → 19.52M (in $), with an average decrease of 13.9% per quarter
About Y-mabs Therapeutics Inc.
| Organisation | Y-mabs Therapeutics Inc. |
| Headquarters | 202 Carnegie Center, Princeton, NJ, United States, 08540 |
| Industry | Health Technology |
| CEO | Mr. Michael Rossi |
| E-voting on shares | Click here to vote |
Key Management of Y-mabs Therapeutics Inc.
Name | Title |
|---|---|
Ms. Natalie Tucker | Senior VP & Radiopharmaceutical Business Unit Head |
Mr. Michael Rossi | CEO, President & Director |
Mr. Thomas Gad | Founder, Chief Business Officer & Vice Chairman |
Mr. Joris Wiel Jan Wilms | Senior VP & COO |
Dr. Torben Lund-Hansen M.Sc., Ph.D. | Senior VP & CTO |
Mr. John W. LaRocca Esq. | Senior VP, General Counsel, Secretary & Chief Legal Officer |
Mr. Peter P. Pfreundschuh CPA | Executive VP, CFO & Treasurer |
Ms. Courtney Dugan | VP & Head of Investor Relations |
Dr. Norman D. LaFrance FACNP, FACP, M.D. | Chief Development Officer & Chief Medical Officer |
Mr. Doug Gentilcore | Senior VP & Head of DANYELZA Business Unit |
FAQs
What is Y-mabs Therapeutics Inc. share price today?
Y-mabs Therapeutics Inc. share price today is $8.6 as on at the close of the market. Y-mabs Therapeutics Inc. share today touched a day high of $8.61 and a low of $8.59.
What is the 52 week high and 52 week low for Y-mabs Therapeutics Inc. share?
Y-mabs Therapeutics Inc. share touched a 52 week high of $16.11 on and a 52 week low of $3.55 on . Y-mabs Therapeutics Inc. stock price today i.e. is closed at $8.6,which is 46.62% down from its 52 week high and 142.25% up from its 52 week low.
What is Y-mabs Therapeutics Inc.'s market capitalisation today?
Y-mabs Therapeutics Inc. market capitalisation is $0.00T as on .
How to invest in Y-mabs Therapeutics Inc. Stock (YMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Y-mabs Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Y-mabs Therapeutics Inc. Shares that will get you 0.1744 shares as per Y-mabs Therapeutics Inc. share price of $8.6 per share as on September 16, 2025 at 1:29 am IST.
What is the minimum amount required to buy Y-mabs Therapeutics Inc. Stock (YMAB) from India?
Indian investors can start investing in Y-mabs Therapeutics Inc. (YMAB) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Y-mabs Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Y-mabs Therapeutics Inc. share’s latest price of $8.6 as on September 16, 2025 at 1:29 am IST, you will get 1.1628 shares of Y-mabs Therapeutics Inc.. Learn more about
fractional shares .
What are the returns that Y-mabs Therapeutics Inc. has given to Indian investors in the last 5 years?
Y-mabs Therapeutics Inc. stock has given -78.18% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?